Russell Z. Szmulewitz to Protein Kinase Inhibitors
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Protein Kinase Inhibitors.
Connection Strength
0.802
-
Vemurafenib oral bioavailability: an insoluble problem. J Clin Pharmacol. 2014 Apr; 54(4):375-7.
Score: 0.356
-
Playing Russian roulette with tyrosine kinase inhibitors. Clin Pharmacol Ther. 2013 Mar; 93(3):242-4.
Score: 0.326
-
Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Invest New Drugs. 2018 10; 36(5):919-926.
Score: 0.120